Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
Biotech
Sanofi pays $110M upfront for late-stage radioligand therapy
Sanofi has made a late entry to the radioligand party, paying 100 million euros for a neuroendocrine tumor drug that is nearing a filing for approval.
Nick Paul Taylor
Sep 12, 2024 4:54am
Siemens Healthineers buys Novartis' EU radiodiagnostic network
Aug 26, 2024 11:30am
SK inks $572M deal for Full-Life radiopharma prospect
Jul 17, 2024 9:18am
Lantheus acquires Alzheimer’s PET diagnostic developer Meilleur
Jul 15, 2024 11:30am
Radiopharma Pentixapharm buys Glycotope antibody discovery unit
Jul 3, 2024 8:51am
Lilly signs $140M radiopharma partnership with Radionetics
Jul 1, 2024 11:06am